EP1689419A4 - Pharmaceutical compositions including low dosages of desmopressin - Google Patents

Pharmaceutical compositions including low dosages of desmopressin

Info

Publication number
EP1689419A4
EP1689419A4 EP03781836A EP03781836A EP1689419A4 EP 1689419 A4 EP1689419 A4 EP 1689419A4 EP 03781836 A EP03781836 A EP 03781836A EP 03781836 A EP03781836 A EP 03781836A EP 1689419 A4 EP1689419 A4 EP 1689419A4
Authority
EP
European Patent Office
Prior art keywords
desmopressin
pharmaceutical compositions
compositions including
including low
low dosages
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03781836A
Other languages
German (de)
French (fr)
Other versions
EP1689419A1 (en
Inventor
Seymour N Fein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Reprise Biopharmaceutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34589310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1689419(A4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reprise Biopharmaceutics LLC filed Critical Reprise Biopharmaceutics LLC
Priority to EP11000467A priority Critical patent/EP2322197A2/en
Priority to EP11000464A priority patent/EP2322194A2/en
Priority to EP11000466A priority patent/EP2322196A2/en
Priority to EP11000468A priority patent/EP2322198A2/en
Priority to EP11000465A priority patent/EP2322195A2/en
Publication of EP1689419A1 publication Critical patent/EP1689419A1/en
Publication of EP1689419A4 publication Critical patent/EP1689419A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
EP03781836A 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin Withdrawn EP1689419A4 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP11000467A EP2322197A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP11000464A EP2322194A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP11000466A EP2322196A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP11000468A EP2322198A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP11000465A EP2322195A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/035662 WO2005046707A1 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin

Publications (2)

Publication Number Publication Date
EP1689419A1 EP1689419A1 (en) 2006-08-16
EP1689419A4 true EP1689419A4 (en) 2009-01-14

Family

ID=34589310

Family Applications (6)

Application Number Title Priority Date Filing Date
EP11000468A Withdrawn EP2322198A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP11000465A Withdrawn EP2322195A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP11000464A Withdrawn EP2322194A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP11000467A Withdrawn EP2322197A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP03781836A Withdrawn EP1689419A4 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP11000466A Withdrawn EP2322196A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin

Family Applications Before (4)

Application Number Title Priority Date Filing Date
EP11000468A Withdrawn EP2322198A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP11000465A Withdrawn EP2322195A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP11000464A Withdrawn EP2322194A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin
EP11000467A Withdrawn EP2322197A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP11000466A Withdrawn EP2322196A2 (en) 2003-11-10 2003-11-10 Pharmaceutical compositions including low dosages of desmopressin

Country Status (6)

Country Link
EP (6) EP2322198A2 (en)
JP (1) JP5596252B2 (en)
CN (1) CN1878563A (en)
AU (1) AU2003287591C1 (en)
CA (2) CA2866501A1 (en)
WO (1) WO2005046707A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
EP2322198A2 (en) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
ATE324869T1 (en) 2003-11-13 2006-06-15 Ferring Bv BLISTER PACKAGING AND SOLID DOSAGE FORM CONTAINING DESMOPRESSIN
SE0600482L (en) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Pharmaceutical composition comprising desmopressin, silica and starch
BRPI0807698A2 (en) 2007-02-27 2015-06-16 Ivax Pharmaceuticals Ireland Inhaler with Dispenser
ES2319054B1 (en) 2007-08-06 2010-02-12 Gp Pharm S.A. ORAL PHARMACEUTICAL COMPOSITION OF DESMOPRESINA.
KR20140143461A (en) * 2007-08-06 2014-12-16 알레간 인코포레이티드 Methods and devices for desmopressin drug delivery
US20100286045A1 (en) * 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
HUE046050T2 (en) * 2008-05-21 2020-01-28 Ferring Bv Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
KR20170081711A (en) * 2008-12-22 2017-07-12 알레간 인코포레이티드 A device for intranasal desmopressin administration
CA2765221C (en) 2009-06-18 2017-10-03 Allergan, Inc. Safe desmopressin administration
AU2014293141A1 (en) 2013-07-23 2016-02-18 Serenity Pharmaceuticals Llc Methods and compositions comprising desmopressin in combination with a beta-3 adrenergic receptor agonist
CA2919194A1 (en) 2013-07-23 2015-01-29 Allergan, Inc. Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor
WO2015063602A1 (en) * 2013-10-29 2015-05-07 Ferring B.V. Desmopressin and blood glucose
MX2017006655A (en) * 2014-11-20 2018-03-12 Allergan Inc Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist.
US10617712B2 (en) 2016-01-29 2020-04-14 Kit Co. Ltd. Solid preparation, method for producing solid reparation, and method for generating hydrogen
US11707063B2 (en) 2016-08-23 2023-07-25 Bosquet Silicon Corp. Compound, production method therefor, and hydrogen supply method
CN110191699A (en) 2016-08-23 2019-08-30 小林光 Hydrogen supplying material and its manufacturing method and method of supplying hydrogen
US10952959B2 (en) * 2017-01-11 2021-03-23 Ferring B.V. Fast disintegrating pharmaceutical composition
CN114432424B (en) * 2021-12-27 2023-06-27 南通联亚药业股份有限公司 Stable aluminum-plastic package desmopressin tablet

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003094886A2 (en) * 2002-05-07 2003-11-20 Ferring Bv Desmopressin in an orodispersible dosage form
WO2004041153A2 (en) * 2002-05-07 2004-05-21 Fein Seymour H Pharmaceutical composition including low dosages of desmopressin

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072668A (en) 1973-11-06 1978-02-07 The Salk Institute For Biological Studies LH-RH Analogs
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4285858A (en) * 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
IE53696B1 (en) 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
ATE24964T1 (en) 1981-12-11 1987-01-15 Wyeth John & Brother Ltd PROCESS FOR THE MANUFACTURE OF SOLID MOLDED OBJECTS.
DE3264450D1 (en) 1981-12-11 1985-08-01 Wyeth John & Brother Ltd Process and apparatus for freezing a liquid medium
US5188825A (en) 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
EP0651997B1 (en) 1991-12-24 1998-10-28 Yamanouchi Pharmaceutical Co. Ltd. Intrabuccally disintegrating preparation and production thereof
IL105553A (en) 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
ATE193892T1 (en) * 1993-06-29 2000-06-15 Ferring Bv SYNTHESIS OF CYCLIC PEPTIDES
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
WO1995001782A2 (en) 1993-07-09 1995-01-19 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
GB9421836D0 (en) 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
US5738875A (en) 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
US5837287A (en) 1994-10-28 1998-11-17 R P Scherer Corporation Process for preparing solid pharmaceutical dosage forms
US5989835A (en) * 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
GB9702799D0 (en) 1997-02-12 1997-04-02 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms
US5925730A (en) 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
US5976577A (en) 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
GB9722682D0 (en) 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
DE10001390A1 (en) 2000-01-14 2001-07-19 Hepavec Ag Fuer Gentherapie Cell line for the production and production of sheep adenovirus vectors
EP2322198A2 (en) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003094886A2 (en) * 2002-05-07 2003-11-20 Ferring Bv Desmopressin in an orodispersible dosage form
WO2004041153A2 (en) * 2002-05-07 2004-05-21 Fein Seymour H Pharmaceutical composition including low dosages of desmopressin

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AGNOLI G C ET AL: "Low-dose desmopressin infusion: renal action in healthy women in moderate salt retention and depletion, and interactions with prostanoids.", PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, vol. 67, no. 4, October 2002 (2002-10-01), pages 263 - 273, XP002505856, ISSN: 0952-3278 *
GROSSMAN A ET AL: "TWO NEW MODES OF DESMOPRESSIN (DDAVP) ADMINISTRATION", BRITISH MEDICAL JOURNAL, LONDON, GB, vol. 280, no. 6225, 17 May 1980 (1980-05-17), pages 1215, XP009003428, ISSN: 0267-0623 *
JANKNEGT ET AL: "Oral Desmopressin as a New Treatment Modality for Primary Nocturnal Enuresis in Adolescents and Adults: A Double-Blind, Randomized, Multicenter Study", JOURNAL OF UROLOGY, BALTIMORE, MD, US, vol. 157, no. 2, 1 February 1997 (1997-02-01), pages 513 - 517, XP005573964, ISSN: 0022-5347 *
See also references of WO2005046707A1 *

Also Published As

Publication number Publication date
CA2545194C (en) 2014-10-21
AU2003287591A1 (en) 2004-06-06
EP2322195A2 (en) 2011-05-18
JP5596252B2 (en) 2014-09-24
EP2322197A2 (en) 2011-05-18
CA2545194A1 (en) 2005-05-26
AU2003287591B2 (en) 2009-06-04
EP2322198A2 (en) 2011-05-18
AU2003287591C1 (en) 2009-12-10
JP2007521244A (en) 2007-08-02
EP2322194A2 (en) 2011-05-18
WO2005046707A1 (en) 2005-05-26
CA2866501A1 (en) 2005-05-26
EP1689419A1 (en) 2006-08-16
CN1878563A (en) 2006-12-13
AU2003287591A8 (en) 2005-06-06
EP2322196A2 (en) 2011-05-18

Similar Documents

Publication Publication Date Title
AU2003299480A8 (en) Pharmaceutical composition including low dosages of desmopressin
GB0321607D0 (en) Manufacture of pharmaceutical compositions
IL173930A0 (en) Pharmaceutical compositions containing forms of r-baclofen
AU2003287591A8 (en) Pharmaceutical compositions including low dosages of desmopressin
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
GB2389530B (en) Pharmaceutical compositions
ZA200605080B (en) Pharmaceutical compositions
GB2391473B (en) Pharmaceutical compositions
GB0300531D0 (en) Pharmaceutical compositions
GB0300427D0 (en) Pharmaceutical composition
EP1648411A4 (en) Pharmaceutical compositions
EP1699458A4 (en) Pharmaceutical composition
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
EP1655029A4 (en) Medicinal compositions
GB0213481D0 (en) Pharmaceutical compositions
GB0300885D0 (en) Pharmaceutical composition
GB0306933D0 (en) Pharmaceutical composition
GB0327742D0 (en) Novel uses of known drugs
SG147453A1 (en) Pharmaceutical aerosol compositions
GB0305579D0 (en) Pharmaceutical compositions
GB0307869D0 (en) Pharmaceutical composition
PL370907A1 (en) Pharmaceutical compositions
GB0307862D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060602

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1094541

Country of ref document: HK

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: REPRISE BIOPHARMACEUTICS, LLC

RIN1 Information on inventor provided before grant (corrected)

Inventor name: FEIN, SEYMOUR N.

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/11 20060101AFI20081202BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20081211

17Q First examination report despatched

Effective date: 20090317

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/11 20060101AFI20101229BHEP

Ipc: A61P 13/00 20060101ALI20101229BHEP

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

19A Proceedings stayed before grant

Effective date: 20110328

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ALLERGAN, INC.

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: REPRISE BIOPHAMACEUTICS, LLC

19F Resumption of proceedings before grant (after stay of proceedings)

Effective date: 20170601

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

19F Resumption of proceedings before grant (after stay of proceedings)

Effective date: 20230102

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20230102

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: FERRING B.V.

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1094541

Country of ref document: HK